Drug Shortage Report for SYLVANT

Last updated on 2025-03-28 History
Report ID 252358
Drug Identification Number 02435136
Brand name SYLVANT
Common or Proper name SYLVANT
Company Name RECORDATI RARE DISEASES CANADA INC
Market Status MARKETED
Active Ingredient(s) SILTUXIMAB
Strength(s) 400MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 1 X 30 ML vial
ATC code L04AC
ATC description IMMUNOSUPPRESSANTS
Reason for shortage Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date 2025-03-06
Estimated end date 2025-03-31
Actual end date 2025-03-27
Shortage status Resolved
Updated date 2025-03-28
Company comments 100 mg/vial strength is available for distribution and can be used in place of the 400 mg/vial until the stock is available.
Health Canada comments
Tier 3 Status No
Contact Address 3080 YONGE STREET, SUITE 6060
TORONTO, ONTARIO
CANADA M4N 3N1
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2025-03-28 English Compare
v3 2025-03-27 English Compare
v2 2025-03-11 French Compare
v1 2025-03-11 English Compare

Showing 1 to 4 of 4